A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression, per a study.| Pulmonary Hypertension News
Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy candidate CS1.| Pulmonary Hypertension News